The effects of promoting colorectal cancer screening on screening utilisation: Evaluation of the German campaign "aktiv gegen darmkrebs" (action against colorectal cancer)

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 11, 2006, Pages 1127-1134

  Loss, Julika ^a   Eichhorn, C ^a   Nagel, E ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Campaign; Colonoscopy; Colorectal cancer; Evaluation; FOBT; Prevention

Indexed keywords

ADENOMA; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OCCULT BLOOD; PHYSICIAN;

COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; GERMANY; GUIDELINE ADHERENCE; HEALTH PROMOTION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PHYSICIAN'S PRACTICE PATTERNS; PROGRAM EVALUATION; QUESTIONNAIRES;

EID: 33845425075     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927082     Document Type: Article

References (38)

1. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland. Krebs in Deutschland - Häufigkeiten und Trends. Saarbrücken, 2004; 4 ed
2. Winawer SJ, Zauber AC, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-1981
3. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371
4. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477
5. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471
6. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995; 155: 1741-1748
7. Rex DK, Lehman GA, Ulbright TM et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993; 88: 825-831
8. Citarda F, Tomaselli G, Capocaccia R et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001; 48: 812-815
9. Brenner H, Arndt V, Sturmer T et al. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001; 85: 972-976
10. Sieg A. Für die BNGS. Screeningkoloskopie bei Personen zwischen 50 und 60 Jahren mit und ohne familiäres Risiko für Kolonkarzinom - eine prospektive Multizenterstudie (Screening colonoscopy among persons 50 to 60 years of age with and without familial risk of colorectal cancer - a prospective multicenter trial). Z Gastroenterol 2003; 41: 1077-1082
11. Bundesärztekammer, Kassenärztliche Bundesvereinigung. Früherkennung des Kolonkarzinoms: Ergänzung der bestehenden Maßnahmen um die qualitätsgesicherte, hohe Koloskopie. Dtsch Arztebl 2002; 99: A2648-A2653
12. Huppe D, Lemberg L, Felten C. Diagnostische Bedeutung und Akzeptanz der Vorsorgekoloskopie - erste Ergebnisse (Effectiveness and patient tolerance of screening colonoscopy - first results). Z Gastroenterol 2004; 42: 591-598
13. Sieg A, Theilmeier A. Ergebnisse der Vorsorge-Koloskopie 2005. Internet-basierte Dokumentation (Results of coloscopy screening in 2005 - an Internet-based documentation). Dtsch Med Wochenschr 2006; 131: 379-383
14. von Betzler M. Prevention des kolorektalen Karzinoms: Frühzeitige Entfernung von Adenomen senkt das Risiko (Early detection of colorectal carcinoma. Pros and cons). MMW Fortschr Med 2005; 147: 26-28
15. Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med 2000; 31: 410-416
16. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997; 89: 1406-1422
17. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med 2003; 36: 525-535
18. Wender RC. Barriers to screening for colorectal cancer. Gastrointest Endosc Clin N Am 2002; 12: 145-170
19. Wolf RL, Zybert P, Brouse CH et al. Knowledge, beliefs, and barriers relevant to colorectal cancer screening in an urban population: a pilot study. Fam Community Health 2001; 24: 34-47
20. Keighley MR. Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 2003; 18 (Suppl 3): 7-30
21. Stone EG, Morton SC, Hulscher ME et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136: 641-651
22. Gerst T. Darmkrebsfrüherkennung: eine Krankheit soll enttabuisiert werden. Dtsch Arztebl 2002; 99: A695-A697
23. Riemann JF. Kolorektales Karzinom: Vermeiden statt leiden (Colorectal carcinoma: prevention instead of suffering). Dtsch Med Wochenschr 2003; 128: 2581-2582
24. Birkner BR. Darmkrebsfrüherkennung - mehr Wissen, schneller Handeln, gesundes Leben erhalten. Bayer Ärztebl 2003; 42: 112-114
25. Loss J, Eichhorn C, Nagel E. Der Kenntnisstand der bayerischen Bevölkerung ab 50 Jahre über Darmkrebsprävention - Untersuchung in zwei Landkreisen (Knowledge of colorectal cancer prevention in the Bavarian population above 50 years - survey in two districts). Gesundheitswesen 2005; 67: 455-460
26. Northover JM. Staging and management of colorectal cancer. World J Surg 1997; 21: 672-677
27. Imperiale TF, Wagner DR, Lin CY et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002; 346: 1781-1785
28. Menges M, Fischinger J, Gartner B et al. Screening colonoscopy in 40- to 50-year-old first-degree relatives of patients with colorectal cancer is efficient: a controlled multicentre study. Int J Colorectal Dis 2006; 21: 301-307
29. Hart AR, Barone TL, Gay SP et al. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England. J Epidemiol Community Health 1997; 51: 187-191
30. Guidry JJ, Fagan P. The readability levels of cancer-prevention materials targeting African Americans. J Cancer Educ 1997; 12: 108-113
31. Kroeber-Riel W, Weinberg P. Konsumentenverhalten. München: Verlag Vahlen, 2003; 8 ed
32. Zapka JG, Lemon SC. Interventions for patients, providers, and health care organizations. Cancer 2004; 101: 1165-1187
33. Nutbeam D. Evaluating health promotion - progress, problems and solutions. Health Promot Int 1998; 13: 27-44
34. Rootman I, Goodstadt M, Potvin L et al. A framework for health promotion evaluation. WHO Reg Publ Eur Ser 2001: 7-38
35. Britton A, Thorogood M, Coombes Y et al. Search for evidence of effective health promotion. Quantitative outcome evaluation with qualitative process evaluation is best. Bmj 1998; 316: 703-704
36. Maar C. Darmkrebs durch Früherkennung besiegen - Die Felix Burda Stiftung und das Netzwerk für Darmkrebsfrüherkennung (Conquering intestinal cancer by early detection - the Felix Burda Foundation and the Network for Early Intestinal Cancer Detection). Z Gastroenterol 2003; 41 (Suppl 1): S32-S33
37. Zylka-Menhorn V. Bayern: Bilanz nach einem Jahr Darmkrebs- Früherkennung. Dtsch Arztebl 2004; 101: A624
38. Pasick RJ, Hiatt RA, Paskett ED. Lessons learned from community-based cancer screening intervention research. Cancer 2004; 101: 1146-1164